• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型肌强直性营养不良中特定 miRNAs 的失调和细胞定位错误。

Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1.

机构信息

Molecular Cardiology Laboratory, IRCCS-Policlinico San Donato, 20097 Milan, Italy.

出版信息

Neuromuscul Disord. 2011 Feb;21(2):81-8. doi: 10.1016/j.nmd.2010.11.012. Epub 2010 Dec 18.

DOI:10.1016/j.nmd.2010.11.012
PMID:21169019
Abstract

Myotonic Dystrophy Type-1 (DM1) is caused by the expansion of a CTG repeat with a peculiar pattern of multisystemic involvement affecting skeletal muscles, the heart, the eye, the central nervous system and the endocrine system. Since microRNA expression is disrupted in several myopathies, the expression of 24 candidate microRNAs was analyzed in skeletal muscle biopsies of 15 DM1 patients. Controls were constituted by biopsies without overt pathological features derived from 14 subjects with suspected neuromuscular disorder of undetermined nature. We found that miR-1 and miR-335 were up-regulated, whereas miR-29b and c, and miR-33 were down-regulated in DM1 biopsies compared to controls. We also found that the cellular distribution of muscle specific miR-1, miR-133b and miR-206 was severely altered in DM1 skeletal muscles. MicroRNA dysregulation was likely functionally relevant, since it impacted on the expression of the predicted miR-1, and miR-29 targets. The observed miRNA dysregulations and myslocalizations may contribute to DM1 pathogenetic mechanisms.

摘要

强直性肌营养不良症 1 型(DM1)是由 CTG 重复扩展引起的,具有多系统受累的特殊模式,影响骨骼肌、心脏、眼睛、中枢神经系统和内分泌系统。由于几种肌病的 microRNA 表达被打乱,我们分析了 15 名 DM1 患者的骨骼肌活检中的 24 种候选 microRNA 的表达。对照组由来自 14 名疑似性质不明的神经肌肉障碍患者的无明显病理特征的活检组成。我们发现,与对照组相比,DM1 活检中 miR-1 和 miR-335 上调,而 miR-29b 和 c 以及 miR-33 下调。我们还发现,肌肉特异性 miR-1、miR-133b 和 miR-206 的肌肉细胞分布在 DM1 骨骼肌中严重改变。microRNA 失调可能具有功能相关性,因为它影响了预测的 miR-1 和 miR-29 靶标的表达。观察到的 microRNA 失调和肌内定位可能有助于 DM1 的发病机制。

相似文献

1
Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1.1 型肌强直性营养不良中特定 miRNAs 的失调和细胞定位错误。
Neuromuscul Disord. 2011 Feb;21(2):81-8. doi: 10.1016/j.nmd.2010.11.012. Epub 2010 Dec 18.
2
Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients.扩展的 CTG 重复触发了果蝇中的 miRNA 改变,这些改变在 1 型肌强直性营养不良患者中是保守的。
Hum Mol Genet. 2013 Feb 15;22(4):704-16. doi: 10.1093/hmg/dds478. Epub 2012 Nov 8.
3
Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients.1 型肌强直性营养不良患者骨骼肌中 microRNA-206 的过表达。
J Transl Med. 2010 May 20;8:48. doi: 10.1186/1479-5876-8-48.
4
Deregulated microRNAs in myotonic dystrophy type 2.肌强直性营养不良 2 型中的失调 microRNAs。
PLoS One. 2012;7(6):e39732. doi: 10.1371/journal.pone.0039732. Epub 2012 Jun 29.
5
microRNA-mRNA expression profiles in the skeletal muscle of myotonic dystrophy type 1.1 型肌强直性营养不良骨骼肌中的 microRNA-mRNA 表达谱。
Neurol Res. 2024 Jul;46(7):613-625. doi: 10.1080/01616412.2024.2339102. Epub 2024 Apr 11.
6
High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2.在 1 型肌强直性营养不良患者中对 RNA 诱导沉默复合物进行高通量分析,确定了 miR-29c 及其靶标 ASB2 的失调。
Cell Death Dis. 2018 Jun 28;9(7):729. doi: 10.1038/s41419-018-0769-5.
7
Deregulation of microRNAs in blood and skeletal muscles of myotonic dystrophy type 1 patients.1型强直性肌营养不良患者血液和骨骼肌中微小RNA的失调
Neurol India. 2017 May-Jun;65(3):512-517. doi: 10.4103/neuroindia.NI_237_16.
8
Micro-RNA expression in muscle and fiber morphometry in myotonic dystrophy type 1.1型强直性肌营养不良症中肌肉的微小RNA表达及纤维形态测定
Neurol Sci. 2017 Apr;38(4):619-625. doi: 10.1007/s10072-017-2811-2. Epub 2017 Jan 11.
9
Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2.1 型和 2 型肌强直性营养不良患者Ⅰ型和Ⅱ型骨骼肌纤维中人胰岛素受体基因(INSR)的可变剪接。
Mol Cell Biochem. 2013 Aug;380(1-2):259-65. doi: 10.1007/s11010-013-1681-z. Epub 2013 May 11.
10
Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.强直性肌营养不良的肌肉病理学:18例患者的光镜和电镜研究
Folia Morphol (Warsz). 2011 May;70(2):121-9.

引用本文的文献

1
circARHGAP10 as a candidate biomarker and therapeutic target in myotonic dystrophy type 1.环状 ARHGAP10 作为 1 型强直性肌营养不良的候选生物标志物和治疗靶点。
Mol Ther Nucleic Acids. 2025 Jul 30;36(3):102646. doi: 10.1016/j.omtn.2025.102646. eCollection 2025 Sep 9.
2
Multisystem Symptoms in Myotonic Dystrophy Type 1: A Management and Therapeutic Perspective.1型强直性肌营养不良的多系统症状:管理与治疗视角
Int J Mol Sci. 2025 Jun 2;26(11):5350. doi: 10.3390/ijms26115350.
3
Myotonic Dystrophy type 2 unmasked by physical activity resumption following COVID-19 lockdown: case discussion and review of the literature.
2型强直性肌营养不良在新冠疫情封锁后恢复体力活动时被发现:病例讨论及文献综述
Acta Myol. 2024 Dec;43(4):134-138. doi: 10.36185/2532-1900-612.
4
Muscle-specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1.肌肉特异性基因编辑改善了1型强直性肌营养不良小鼠模型中的分子和表型缺陷。
Clin Transl Med. 2025 Feb;15(2):e70227. doi: 10.1002/ctm2.70227.
5
New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target.1型强直性肌营养不良的新视野:细胞衰老作为治疗靶点
Bioessays. 2025 Mar;47(3):e202400216. doi: 10.1002/bies.202400216. Epub 2024 Dec 26.
6
MBNL splicing factors regulate the microtranscriptome of skeletal muscles.MBNL 剪接因子调节骨骼肌的微转录组。
Nucleic Acids Res. 2024 Oct 28;52(19):12055-12073. doi: 10.1093/nar/gkae774.
7
Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle Regeneration.研究 MBNL1 和 MBNL2 缺失对骨骼肌再生的影响。
Int J Mol Sci. 2024 Feb 26;25(5):2687. doi: 10.3390/ijms25052687.
8
MicroRNAs as a Tool for Differential Diagnosis of Neuromuscular Disorders.微小 RNA 作为神经肌肉疾病鉴别诊断的工具。
Neuromolecular Med. 2023 Dec;25(4):603-615. doi: 10.1007/s12017-023-08763-0. Epub 2023 Oct 19.
9
Individual transcriptomic response to strength training for patients with myotonic dystrophy type 1.1 型肌强直性营养不良患者抗阻训练的个体转录组反应。
JCI Insight. 2023 Jul 24;8(14):e163856. doi: 10.1172/jci.insight.163856.
10
CRISPR-Cas9 editing of a TNPO3 mutation in a muscle cell model of limb-girdle muscular dystrophy type D2.在D2型肢带型肌营养不良症的肌肉细胞模型中对TNPO3突变进行CRISPR-Cas9编辑。
Mol Ther Nucleic Acids. 2023 Jan 11;31:324-338. doi: 10.1016/j.omtn.2023.01.004. eCollection 2023 Mar 14.